Vitamin D and the Prevention of Morbidity and Mortality in Dialysis Patients

ASN Renal Week, Official Evening Symposium
San Diego, CA, November, 2003
Introduction and Welcome (not recorded)
Stuart Sprague, DO; Jorge Cannata-Andia, MD, PhD

Overview of Vitamin D Biology
Sharon Moe, MD

Nonclassical Actions of Vitamin D
Gary Schwartz, MPH, PhD

Cardiovascular Effects of Vitamin D
Gerard London, MD
Vitamin D, a Potential Factor for Survival in Dialysis
Ravi Thadhani, MD
Questions and Answers
Speakers and moderator
Final Remarks
Jorge Cannata-Andia, MD, PhD

Jorge Cannata-Andia, MD, PhD
Professor of Nephrology
Universidad de Oviedo
Director, Bone and Mineral Research Unit
Hospital Universitario Central de Asturias
Oviedo, Spain

Gerard London, MD
Chief of the department of Nephrology-Hemodialysis
Hopital Manhes
Fleury-Merogis, France

Sharon Moe, MD
Associate Professor of Medicine
Assistant Dean for Research Support
Indiana University School of Medicine
Indianapolis, IN

Gary Schwartz, MPH, PhD

Associate Professor of Cancer Biology
Scientific Director of the Prostate Cancer Center of Excellence
Wake Forest University School of Medicine
Winston-Salem, NC

Stuart Sprague, DO
Associate Professor of Medicine
Northwestern University School of Medicine
Metabolic Bone and Stone Disease Program
Evanston Hospital
Evanston, IL

Ravi Thadhani, MD
Assistant Professor of Medicine
Harvard Medical School
Boston, MA

This group of talks is accredited for up to 2.0 CME Category 1 credits by the American Society of Nephrology. This group of talks has a single post-test, which must be completed along with an evaluation form to obtain Category 1 credit. The links to the post-test appear on the individual talk pages.
Date of Web Release: February 1, 2004
CME Credit Eligible Through: May 1, 2005
CME Category 1 Credits/Completion Time: 2.0
Target Audiences: Nephrology Board and Recertification candidates practicing nephrologists and internists.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations.
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Nephrology designates this educational activity for a maximum of 2.0 hours of category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.
This official evening symposium was sponsored by an educational grant from Abbott Laboratories, Inc.
American Society of Nephrology as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants. Speaker disclosures are posted on each individual talk page.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media ( is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME certificate, and this can be download free from

For any questions concerning this specific activity please send an email to or, or call HDCN at 630-325-3276.

For any general questions concerning ASN CME, please contact the American Society of Nephrology.